Page 87 - Read Online
P. 87

oxidative  phosphorylation,  even  under  normoxic   Financial support and sponsorship
            conditions.  Aberrant  metabolism  in  tumor  cells  can
            generate  the  abnormally  high  levels  of  reactive  oxygen   Nil.
            species  (ROS),  which  induce  senescence  or  apoptosis.   Confl icts of interest
            To counter such oxidative stress, cancer cells exert tight   There are no confl icts of interest.
            regulation  of  ROS  and  antioxidants  in  such  a  way  that
            the  cell  survives  and  the  levels  of  ROS  are  reduced  to   References
            moderate levels.  Sawayama et al. review the molecular
                         [2]
            mechanism  of  cancer  metabolism,  and  demonstrate   1.   Torre  LA,  Bray  F,  Siegel  RL,  Ferlay  J,  Lortet-Tieulent  J,
            possible therapeutic strategies targeting metabolism.  Jemal  A.    Global  cancer  statistics,   2012.  CA Cancer J Clin
                                                                  2015;65:87-108.
                Molecular   targeted   drugs   block   the   pathways   2.   Cairns  RA,  Harris  IS,  Mak  TW.  Regulation  of  cancer  cell
            specifi cally  involved  in  tumorigenesis  and  the   metabolism. Nat Rev Cancer 2011;11:85-95.
            progression  of  cancers.  Several  targeted  drugs  have
            already  been  introduced  into  cancer  treatment,  and   This is an open access article distributed under the terms of the Creative
                                                              Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows
            vascular  endothelial  growth  factor  and  epithelial   others to remix, tweak, and build upon the work non-commercially, as long as
            growth  factor  receptor  are  two  major  targets  in  the   the author is credited and the new creations are licensed under the identical
                                                              terms.
            treatment  for  colorectal  cancer.  An  antibody  targets
            HER-2 has become a standard choice for gastric cancer   For reprints contact: reprints@medknow.com
            with  HER-2  overexpression/amplifi cation.  Currently,           Access this article online
            many  candidate-targeted  agents  are  under  clinical  or
            preclinical  study.  Eto  et al.  summarize  trends  in  the   Quick Response Code:  Website:
            clinical use of targeted drugs for GI cancers.                          www.jcmtjournal.com
            All of nine, fi rst authors of review articles in this issue are
            young researchers who had started their research career at              DOI:
            the Department of Gastroenterological Surgery, Graduate                 10.4103/2394-4722.166973
            School  of  Medical  Sciences,  Kumamoto  University.
            I  would  like  to  express  my  sincere  appreciation  to   How to cite this article: Watanabe M. Introduction to Volume 1 Issue 3
            Prof. Hideo Baba and all members in his department for   of Journal of Cancer Metastasis and Treatment. J Cancer Metastasis
            their  guidance  and  support  for  this  project.  I  am  very   Treat 2015;1:111-2.
            happy if you enjoyed this special issue.           Received: 17-08-2015; Accepted: 31-08-2015.








































            112                                   Journal of Cancer Metastasis and Treatment  ¦  Volume 1 ¦ Issue 3 ¦ October 15, 2015 ¦
   82   83   84   85   86   87   88   89   90   91   92